Literature DB >> 22234634

Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Brian Shuch1, Gennady Bratslavsky, W Marston Linehan, Ramaprasad Srinivasan.   

Abstract

Recent advancements in the molecular characterization of renal cell carcinoma altered the classification system and now kidney cancer is divided into several distinct histologic subtypes. Although once a separate histologic category, sarcomatoid renal cell carcinoma is no longer considered a separate tumor type because it can occur with all histologic subtypes. Limited research on tumors with sarcomatoid change has led to minimal progress in the understanding and treatment of these tumors. Because the sarcomatoid variant of renal cell carcinoma can account for approximately one in six cases of advanced kidney cancer, we hope to familiarize clinicians with these tumors by describing the historic background, histologic features, molecular characterization, diagnosis, prognosis, treatment strategies, and active clinical trials of this aggressive type of tumor.

Entities:  

Mesh:

Year:  2012        PMID: 22234634      PMCID: PMC3267822          DOI: 10.1634/theoncologist.2011-0227

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  61 in total

1.  Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. I.

Authors:  G M Farrow; E G Harrison; D C Utz; W H ReMine
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

2.  Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy.

Authors:  T Cangiano; J Liao; J Naitoh; F Dorey; R Figlin; A Belldegrun
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

3.  Sarcomatoid carcinoma of the kidney.

Authors:  F Bertoni; C Ferri; A Benati; P Bacchini; F Corrado
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

4.  Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.

Authors:  M de Peralta-Venturina; H Moch; M Amin; P Tamboli; S Hailemariam; M Mihatsch; J Javidan; H Stricker; J Y Ro; M B Amin
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

Review 5.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

6.  Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation.

Authors:  F Jiang; H Moch; J Richter; C Egenter; T Gasser; L Bubendorf; R Gschwind; G Sauter; M J Mihatsch
Journal:  J Pathol       Date:  1998-08       Impact factor: 7.996

7.  A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.

Authors:  Michael L Blute; Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

8.  Fine-needle aspiration cytology of sarcomatoid renal cell carcinoma: a morphologic and immunocytochemical study of 15 cases.

Authors:  M Auger; R L Katz; A Sella; N G Ordóñez; D D Lawrence; J Y Ro
Journal:  Diagn Cytopathol       Date:  1993       Impact factor: 1.582

9.  Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response.

Authors:  S A Rosenberg; J C Yang; D E White; S M Steinberg
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Ultrastructural study of a sarcomatoid variant of renal cell carcinoma.

Authors:  B Deitchman; G S Sidhu
Journal:  Cancer       Date:  1980-09-01       Impact factor: 6.860

View more
  59 in total

1.  Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape.

Authors:  Zixing Wang; Tae Beom Kim; Bo Peng; Jose Karam; Chad Creighton; Aron Joon; Fumi Kawakami; Patricia Trevisan; Eric Jonasch; Chi-Wan Chow; Jaime Rodriguez Canales; Pheroze Tamboli; Nizar Tannir; Christopher Wood; Federico Monzon; Keith Baggerly; Marileila Varella-Garcia; Bogdan Czerniak; Ignacio Wistuba; Gordon Mills; Kenna Shaw; Ken Chen; Kanishka Sircar
Journal:  Clin Cancer Res       Date:  2017-07-14       Impact factor: 12.531

2.  Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).

Authors:  Youfeng Yang; Cathy D Vocke; Christopher J Ricketts; Darmood Wei; Hesed M Padilla-Nash; Martin Lang; Carole Sourbier; J Keith Killian; Shawna L Boyle; Robert Worrell; Paul S Meltzer; Thomas Ried; Maria J Merino; Adam R Metwalli; W Marston Linehan
Journal:  Genes Chromosomes Cancer       Date:  2017-07-24       Impact factor: 5.006

3.  Sarcomatoid renal cell carcinoma: genomic insights from sequencing of matched sarcomatous and carcinomatous components.

Authors:  Brandon J Manley; James J Hsieh
Journal:  Transl Cancer Res       Date:  2016-08       Impact factor: 1.241

4.  Immunotherapy combinations transform the treatment paradigm for advanced renal cell carcinoma.

Authors:  Justin A Shaya; Rana R McKay
Journal:  Ann Transl Med       Date:  2019-12

5.  Presence of sarcomatoid differentiation as a prognostic indicator for survival in surgically treated metastatic renal cell carcinoma.

Authors:  Liangyou Gu; Hongzhao Li; Hanfeng Wang; Xin Ma; Lei Wang; Luyao Chen; Wenlei Zhao; Yu Zhang; Xu Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2016-11-14       Impact factor: 4.553

6.  RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.

Authors:  Sumanta K Pal; Miaoling He; Tommy Tong; Huiqing Wu; Xueli Liu; Clayton Lau; Jin-Hui Wang; Charles Warden; Xiwei Wu; Sabina Signoretti; Toni K Choueiri; Jose A Karam; Jeremy O Jones
Journal:  Mol Cancer Res       Date:  2014-09-02       Impact factor: 5.852

7.  Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma.

Authors:  Abhishek Maiti; Maryam Nemati-Shafaee; Pavlos Msaouel; Lance C Pagliaro; Eric Jonasch; Nizar M Tannir; Amishi Y Shah
Journal:  Clin Genitourin Cancer       Date:  2017-08-10       Impact factor: 2.872

8.  Unusual early-stage pancreatic sarcomatoid carcinoma.

Authors:  Chuan-Li Ren; Ping Jin; Chong-Xu Han; Qin Xiao; Dao-Rong Wang; Lin Shi; Da-Xin Wang; Hui Chen
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 9.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

10.  Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors.

Authors:  Aaron M Goodman; David Piccioni; Shumei Kato; Amélie Boichard; Huan-You Wang; Garrett Frampton; Scott M Lippman; Caitlin Connelly; David Fabrizio; Vincent Miller; Jason K Sicklick; Razelle Kurzrock
Journal:  JAMA Oncol       Date:  2018-09-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.